Zone breakpoints, by the CLSI disc method, for 15 μg tigecycline discs corresponding to EUCAST MIC breakpoints

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 10, 2010, Pages 2262-2264

  Hope, Russell ^a   Pllana, Teresa ^a   James, Dorothy ^a   Warner, Marina ^a   Livermore, David M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Agar dilution; Error minimization; Susceptibility testing

Indexed keywords

TIGECYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; ENTEROBACTERIACEAE; ENTEROCOCCUS; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 77957226578     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq288     Document Type: Letter

References (7)

1. Fluit AC, Florijn A, Verhoef J et al. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline. Antimicrob Agents Chemother 2005; 49: 1636-8.
2. Hirata T, Saito A, Nishino K et al. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936). Antimicrob Agents Chemother 2004; 48: 2179-84.
3. Petersen PJ, Jacobus NV, Weiss WJ et al. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother 1999; 43: 738-44.
4. Andrews JM. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009; 64: 454-89.
5. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
6. BSAC Resistance Surveillance Project. http://www.bsacsurv.org (22 January 2010, date last accessed).
7. EUCAST Disk Diffusion Test for Routine Antimicrobial Susceptibility Testing. http://www.eucast.org/eucast_disk_diffusion_test/ (22 January 2010, date last accessed).